THYROID NEOPLASMS OF PATHOLOGY ROBBINS.pptx

jenishJebadurai1 305 views 42 slides Apr 24, 2024
Slide 1
Slide 1 of 42
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42

About This Presentation

Thyroid malignancy


Slide Content

THYROID NEOPLASMS

15-25 grams

“NODULES” Solitary vs. Multiple Younger vs. Older Male vs. Female Hx. neck radiation vs. NO Rx. “Cold” vs. HOT (really NOT-cold)

SOLITARY NODULES YOUNGER AGE MALES RADIATION HOT NODULES

ADENOMA THYROID Discrete,solitary,from thyroid epithelial cells DD:1. dominant nodule 2.follicular carcinoma nonfunctional.

pathogenesis Mutations of TSH receptor signelling pathway. Gain of function in TSHR or GNAS-Independent secretion of TSH-THYROID AUTONOMY-HOT NODULE RAS OR PIK3 CA

MORPHOLOGY solitary spherical encapsulated Compressing the adjacent thyroid Hge,necrosis,fibrosis and cystic changes

Well formed capsule Uniform follicles Uniform cell size Compression of adjacent thyroid

Clinical features Painless Difficulty in swalowing Non functioning-cold nodules USG ,FNAC

H Ü RTHLE CELL ADENOMA, note “atypia”

CARCINOMAS 4 MAJOR TYPES 1.PAPILLARY CA 2.FOLLICULAR CA 3.ANAPLASTIC CA 4.MEDULLARY CA

Papillary carcinoma 1.RET gene in chr 10-TK receptor expression-RET PTC fusion gene-transcriptional activation 2.BRAF MUTATION-Prognostic significance

ORPHAN ANNIE CELLS in PAPILLARY CARCINOMA

Follicular carcinoma Mutations that activates RAS OR PI3K AKT of TK receptor pathway Translocation of (2;3)(q13;p25)producing PAX8 PPARG FUSION GENE -thyroid development and terminal differentiation of cells

Anaplastic or undifferentiated carcinoma RAS ,PIK3CA MUTATION INACTIVATION OF TP53 or activation of beta catenin

Medullary carcinoma MEN 2 RET mutation

MEDULLARY CARCINOMA of the thyroid with “HYALINIZATION”, i.e., AMYLOID!!!

HYALINIZATION showing APPLE GREEN birefringence in CONGO RED stain, i.e., AMYLOID

Papillary Carcinoma Most common Morphology Branching papillae with central fibro vascular core Uniform cuboidal cells Nuclear Feature Dispersed Chromatin Clear or empty nucleus – Ground glass / Orphan annie eye nucleus Pseudoinclusion , intranuclear grooves psammoma bodies – concentric calcified structure

Variants Tall cell variant Diffuse sclerosing variant Papillary microcarcinoma Follicular variant Columnar cell variant Solid variant Cribriform morular variant Hobnail variant

Clinical Course Hoarseness Dysphagia Cough Dyspnea

Follicular Carcinoma 5 – 15 % Associated with Dietary iodine deficiency

Morphology Gross Similar to Follicular adenoma Microscopy Uniform follicles with colloid , capsular and vascular invasion present Benign Malignant Complete capsule Circumferential fibrosis Compression of adjacent thyroid No compression No Capsular or Vascular invasion Capsular or Vascular invasion seen

Clinical Features Cold Nodules Hematogenous Spread Total Thyroidectomy Serum thyroglobulin – To monitor tumor recurrence

Anaplastic (Undifferentiated ) Carcinoma < 5 % Aggressive Arising from well differentiated thyroid carcinoma

Morphology Highly anaplastic cells including 1)Large pleomorphic giant cells 2) Sarcomatpus spindle cells 3) Mixed spindle and giant cells Positive for cytokeratin

Clinical Features Rapidly enlarging neck mass No surgical treatement

Medullary Carcinoma Neuroendocrine neoplasm dervied from parafollicular cells or ‘C’ cells Secrete Calcitonin Sporadic or Associated with MEN 2A or MEN 2B Familial Medullary thyroid carcinoma

Gross – Solitary nodule Infiltrative Necrosis Hemorrhage Polygonal to spindle shaped cells forming nests, trabeculae and follicles Amyloid deposits C Cell hyperplasia

Clinical course Mass in neck Dysphagia Hoarseness Cushing syndrome Diarrhea Serum Calcitonin Elevated CEA - Biomarker